Revenue is the easiest number to see and the easiest to overtrust
Cash-pay wellness and aesthetic practices usually know top-line revenue quickly. Payment clears at the visit, the scheduler shows daily production, and the owner can feel when the calendar is full. That visibility is useful, but it can create false confidence when the practice is product-heavy.
A medspa, GLP-1 clinic, IV therapy practice, peptide program, or independent injector can increase revenue while margin gets worse. Product cost may rise, higher-dose patients may consume more medication, providers may use more product than planned, packages may include more value than priced, or expired stock may erase the benefit of strong sales.
The better operating question is not just how much the practice sold. It is how much contribution remained after the specific products, lots, doses, supplies, waste, discounts, and provider activity tied to those visits were counted.
1. Gross margin per completed visit
Gross margin per visit is the foundation KPI for a product-heavy cash-pay practice. It connects the actual revenue collected for a visit to the direct cost of what was used to deliver that visit. Without this metric, the practice is judging services by sales volume instead of economic quality.
For injectables, this means the units or fractions used from specific lots. For GLP-1 and weight loss clinics, it means medication dose, vial cost, concentration, waste, and any bundled clinical touchpoints. For IV therapy, it means ingredients, disposables, boosters, and supplies attached to the completed protocol.
The trend matters as much as the number. If margin per visit falls while revenue rises, the practice needs to investigate pricing, provider usage, discounting, product cost, or service mix before the month-end financials make the problem obvious.
2. COGS percentage by service line
COGS percentage shows what share of service revenue is consumed by direct product cost. It should be reviewed by service line, not only for the whole practice. Botox, filler, biostimulators, GLP-1 programs, IV drips, retail, peptides, and hormone-related products all behave differently.
A blended practice-level COGS percentage can hide the issue. One profitable service can subsidize another service that is underpriced, over-discounted, or consuming more product than expected. Owners need to know which categories are expanding margin and which categories are only expanding revenue.
This KPI becomes more useful when it is calculated from point-of-service usage instead of purchase history. Purchase orders show what came in. Visit-level COGS shows what was consumed to create revenue.
3. Provider contribution margin
Provider performance should not be measured by revenue alone. Two providers can produce the same sales number while using different amounts of product, discounting differently, creating different waste, or steering patients toward different service mixes.
Provider contribution margin connects provider revenue to the direct COGS and product movement tied to that provider's visits. It helps owners coach technique, evaluate pricing integrity, design compensation, and understand whether growth depends on healthy provider economics.
This is especially important for injectables and IV therapy because small usage differences repeat across many visits. A few extra units, an unpriced booster, or informal product use can look harmless in one appointment and material across a month.
4. Inventory shrinkage and waste rate
Shrinkage is the gap between what inventory records say should be available and what the practice can actually use. Waste is the portion tied to expired stock, partial product, preparation loss, no-shows, broken packaging, or documentation gaps. Both should be measured, not explained away.
For product-heavy practices, shrinkage is not an admin nuisance. It is margin leaving the business. If a clinic buys expensive injectables, GLP-1 medication, IV ingredients, peptides, or retail stock and cannot connect the movement to a visit, waste event, transfer, or adjustment, profit visibility is incomplete.
A useful KPI separates normal clinical waste from preventable operating waste. The owner should be able to see where it occurred, which product or lot was affected, and whether the same pattern is repeating.
5. Expiration risk by dollar value
Counting soon-to-expire units is useful, but dollar value is what changes behavior. Ten low-cost retail items expiring next month may matter less than one expensive vial, box, or compound lot sitting unused in a refrigerator.
Expiration risk should be visible by product, lot, location, and cost basis. The practice should know which inventory is at risk, what it is worth, whether it can be used safely before expiration, and whether ordering behavior needs to change.
This KPI also supports better cash control. Stock that expires is not only a product problem. It is working capital that was purchased, stored, and never converted into profitable care.
6. Reorder accuracy and stockout frequency
Low stock alerts are not enough. A practice should know whether reorder timing is accurate, whether reorder quantities match actual usage, and how often stockouts interrupt revenue or force substitutions.
Over-ordering creates cash tied up in product and raises expiration risk. Under-ordering creates missed revenue, rushed purchasing, overnight shipping, and operational friction. The KPI to watch is whether inventory planning matches real service demand and product movement.
Reorder accuracy improves when it uses actual usage velocity, not memory. A fast-growing GLP-1 program, a seasonal IV therapy menu, or a new injector's ramp can change product needs faster than a static spreadsheet can keep up.
7. Discount impact on margin
Discounts are common in cash-pay practices, but they should not be evaluated only by revenue lift. A discount can fill the calendar while erasing contribution margin if product costs are high or the service already has tight economics.
The important KPI is margin after discount by service, provider, campaign, and package. This shows whether a promotion created profitable acquisition, moved excess inventory, supported a membership strategy, or simply trained patients to buy below cost structure.
Discounts are easier to manage when the practice knows the true cost floor of each treatment. That floor changes by product, dose, waste, provider usage, and included supplies.
8. Cash conversion from inventory
Cash conversion from inventory asks how efficiently purchased product turns into profitable visits. It connects purchasing, stock on hand, usage, waste, revenue, and margin into one operating view.
A practice with strong bookings can still have weak cash conversion if it buys too early, carries too much slow-moving stock, loses product to expiration, or pushes low-margin services. This KPI keeps the owner focused on the full path from product purchase to margin realized.
The goal is not to minimize inventory at all costs. The goal is to carry enough product to deliver care reliably while avoiding the hidden cost of overstock, stale lots, and revenue that does not translate into profit.
A practical review cadence
Cash-pay operators do not need a finance department to run these KPIs, but they do need a cadence. Daily review should cover stockouts, unusual usage, and high-risk inventory. Weekly review should cover provider margin, service-line COGS, waste, and reorder needs. Monthly review should connect those operating metrics to pricing, packages, compensation, and growth decisions.
The same cadence works across medspas, GLP-1 clinics, IV therapy practices, hormone and peptide programs, and independent providers. The products differ. The operating principle is the same: if product cost drives margin, product movement has to be connected to the visit where revenue was earned.
Otzaro is built around that connection. It treats inventory, COGS, provider usage, ordering, batching, and AI-supported insight summaries as one profit intelligence layer alongside the scheduler or EMR the practice already uses.
The KPI stack should answer these questions
Which services produce the best gross margin after actual product usage is counted?
Which providers generate healthy contribution margin, not just high revenue?
Where are waste, shrinkage, expiration, and stockouts costing the practice money?
Which discounts, packages, and service lines need pricing or workflow changes?
How quickly does purchased inventory turn into profitable care?
FAQ
What KPIs should a cash-pay wellness practice track first?
Start with gross margin per visit, COGS percentage by service line, provider contribution margin, inventory shrinkage, expiration risk by dollar value, reorder accuracy, discount impact, and cash conversion from inventory.
Why is revenue not enough for a cash-pay practice?
Revenue shows what patients paid, but it does not include product cost, waste, discounts, provider usage, expired stock, or reorder decisions. Product-heavy practices need margin KPIs to know whether revenue became profit.
How often should a practice review inventory and margin KPIs?
Daily review should catch urgent stock, usage, and waste issues. Weekly review should cover provider margin, service-line COGS, reorder needs, and expiration risk. Monthly review should inform pricing, compensation, packages, and growth decisions.
Can a spreadsheet track these KPIs?
A spreadsheet can model targets, but it usually breaks when usage needs to connect to specific visits, providers, lots, expiration dates, waste events, discounts, and reorders. Visit-level COGS and inventory movement need to stay current during operations.